Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Magnesium Sulfate for Shivering Prevention in C-Section
NCT03008850Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in postanesthetic shivering (PAS) (2 arms), sponsored by Assiut University. Primary endpoint: Shivering Score at 2 hours. Started Jun 2015; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT03008850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008850.